Patents by Inventor Stacey Bolk

Stacey Bolk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050244834
    Abstract: The invention provides nucleic acid segments of the human genome, particularly nucleic acid segments from a gene, including polymorphic sites. Allele-specific primers and probes hybridizing to regions flanking or containing these sites are also provided. The nucleic acids, primers and probes are used in applications such as phenotype correlations, forensics, paternity testing, medicine and genetic analysis. A role for the thrombospondin gene(s) in vascular disease is also disclosed. Use of single nucleotide polymorphisms in the thrombospondin gene(s) for diagnosis, prediction of clinical course and treatment response, development of therapeutics and development of cell-culture-based and animal models for research and treatment are disclosed.
    Type: Application
    Filed: April 26, 2004
    Publication date: November 3, 2005
    Applicants: Whitehead Institute for Biomedical Research, Millennium Pharmaceuticals, Inc.
    Inventors: Eric Lander, Michele Cargill, James Ireland, Stacey Bolk, George Daley, Jeanette McCarthy
  • Publication number: 20050100953
    Abstract: A role for the thrombospondin gene(s), particularly TSP-2, in vascular disease is disclosed. Use of single nucleotide polymorphisms in the thrombospondin gene(s) for diagnosis, prediction of clinical course and treatment response, development of therapeutics and development of cell-culture-based and animal models for research and treatment are disclosed.
    Type: Application
    Filed: December 22, 2004
    Publication date: May 12, 2005
    Inventors: Stacey Bolk, George Daley, Jeanette McCarthy
  • Patent number: 6727063
    Abstract: The invention provides nucleic acid segments of the human genome, particularly nucleic acid segments from a gene, including polymorphic sites. Allele-specific primers and probes hybridizing to regions flanking or containing these sites are also provided. The nucleic acids, primers and probes are used in applications such as phenotype correlations, forensics, paternity testing, medicine and genetic analysis. A role for the thrombospondin gene(s) in vascular disease is also disclosed. Use of single nucleotide polymorphisms in the thrombospondin gene(s) for diagnosis, prediction of clinical course and treatment response, development of therapeutics and development of cell-culture-based and animal models for research and treatment are disclosed.
    Type: Grant
    Filed: September 7, 2000
    Date of Patent: April 27, 2004
    Assignees: Millennium Pharmaceuticals, Inc., Whitehead Institute for Biomedical Research
    Inventors: Eric S. Lander, Michele Cargill, James S. Ireland, Stacey Bolk, George Q. Daley, Jeanette J. McCarthy
  • Patent number: 6642001
    Abstract: The present invention is drawn to methods for detection, quantitation and analysis of nucleotides of interest in nucleic acid sequences of interest using single base extension and fluorescence resonance energy transfer and generic donor molecule-labeled detection probes.
    Type: Grant
    Filed: July 13, 2000
    Date of Patent: November 4, 2003
    Assignee: Whitehead Institute for Biomedical Research
    Inventors: Stacey Bolk, Joel N. Hirschhorn, James S. Ireland, Eric S. Lander
  • Publication number: 20030194703
    Abstract: A role for the thrombospondin gene(s), particularly TSP-2, in vascular disease is disclosed. Use of single nucleotide polymorphisms in the thrombospondin gene(s) for diagnosis, prediction of clinical course and treatment response, development of therapeutics and development of cell-culture-based and animal models for research and treatment are disclosed.
    Type: Application
    Filed: November 13, 2001
    Publication date: October 16, 2003
    Inventors: Stacey Bolk, George Q. Daley, Jeanette J. McCarthy
  • Publication number: 20030096248
    Abstract: The present invention is based at least in part on the discovery of polymorphisms within the thrombospondin 1 (THBS1) and thrombospondin 4 (THBS4) genes. Accordingly, the invention provides nucleic acid molecules having a nucleotide sequence of an allelic variant of a THBS1 or THBS4 gene. The invention also provides methods for identifying specific alleles of polymorphic regions of a THBS1 or THBS4 gene, methods for determining whether a subject has or is at risk of developing a disease which is associated with a specific allele of a polymorphic region of a THBS1 or THBS4 gene, e.g., a vascular disease, based on detection of polymorphisms within the THBS1 or THBS4 gene, and kits for performing such methods. The invention further provides methods for identifying a subject who has, or is at risk for developing, a vascular disease or disorder as a candidate for a particular clinical course of therapy or a particular diagnostic evaluation.
    Type: Application
    Filed: December 14, 2001
    Publication date: May 22, 2003
    Applicant: Vitivity, Inc.
    Inventors: Jeanette McCarthy, George Q. Daley, Stacey Bolk Gabriel